Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
(NASDAQ: KNSA) Delayed: 77.32 -0.76 (0.97%)
Previous Close $78.08    52 Week High
Open $78.00    52 Week Low
Day High $78.12    P/E N/A 
Day Low $76.65    EPS
Volume 50,378